Quoin Pharmaceuticals QNRX Cash Flow Statement (2017-2026)

NASDAQ QNRX
$3.98 +0.08 (+2.05%)
At close: Oct 19, 2026 · 4:00 PM EDT
Reported Financials

Quoin Pharmaceuticals Quarterly Cash Flow Statement

Periods 24 quarters
Latest Jun 2026

Quoin Pharmaceuticals reported cash from operations of -$3.14M and free cash flow of -$3.14M for the quarter ended Jun 2026, up 14.7% year over year. This cash flow statement covers 24 quarters of results from Dec 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Dec2017 Dec2018 Dec2020 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-1.40M-11.82M-1.68M-2.67M-3.03M-2.00M-2.60M-2.11M-1.93M-2.05M-2.33M-1.97M-2.35M-2.31M-3.81M-3.70M-3.95M-4.35M-5.00M-5.37M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M
Share-based CompensationStock Comp.
0.23M0.27M0.27M0.26M0.26M0.27M0.30M0.31M0.31M0.31M0.33M0.36M0.32M0.18M0.29M0.45M0.53M
Gains from Investment SecuritiesGains Investment
0.08M0.13M0.10M0.14M0.12M0.10M0.02M0.07M0.07M0.07M
Other non-cash itemsOther Non-Cash
-0.15M8.26M-0.49M
Change in Working Capital
Change in Accured ExpensesChange Accured Exp.
0.19M0.89M0.16M0.28M-0.59M-0.07M0.58M0.18M0.29M-1.00M0.64M-0.27M-0.48M0.38M0.67M-0.52M1.43M-0.26M-0.20M1.27M
Change in Other Operating AssetsOther Assets Change
-0.21M0.02M-0.33M0.40M-0.12M-0.16M-0.16M0.40M-0.02M0.08M-0.38M0.60M-0.23M-0.26M-0.09M0.66M0.03M-0.46M
Other Working Capital ChangesOther WC Changes
0.21M-0.02M0.33M-0.40M0.12M0.16M0.16M-0.40M0.02M-0.08M0.38M-0.60M0.23M0.26M0.09M-0.66M-0.03M0.46M
Cash from OperationsCash from Ops.
-0.91M-3.18M-2.09M-2.15M-2.29M-1.94M-1.75M-1.57M-1.32M-3.22M-1.43M-2.01M-2.18M-2.24M-2.59M-3.69M-2.23M-5.04M-4.87M-3.14M
Investing Activities
Purchase of InvestmentsInvestments Purchased
13.49M4.60M9.65M1.61M6.00M0.98M0.98M
Sale and Maturity of InvestmentsInvestments Sold
10.00M3.04M4.60M2.64M5.18M3.16M4.21M2.82M2.77M1.68M2.54M1.00M5.10M5.00M
Cash from Investing ActivitiesCash from Investing
-0.11M-0.25M-0.05M-0.20M-9.90M-3.49M3.04M821.002.64M-4.47M3.16M2.60M-3.18M2.77M1.68M2.54M-11.27M4.12M4.02M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
-0.14M0.14M
Long-Term Debt RepaymentsLT Debt Repayment
0.15M0.15M0.15M0.15M0.46M0.10M0.08M0.28M0.15M0.15M0.15M0.15M0.15M0.15M0.15M0.15M0.15M0.15M0.15M
Non-Current Debt
-0.14M-0.01M-0.15M-0.15M-0.15M-0.46M-0.10M-0.08M-0.28M-0.15M-0.15M-0.15M-0.15M-0.15M-0.15M-0.15M-0.15M-0.15M-0.15M-0.15M
Net Debt Issuances and RepaymentsNet Debt Issuance
-0.14M-0.01M-0.15M-0.15M-0.15M-0.46M-0.10M-0.08M-0.28M-0.15M-0.15M-0.15M-0.15M-0.15M-0.15M-0.15M-0.15M-0.15M-0.15M-0.15M
Change in Capital Stock
Common Stock IssuedStock Issued
-0.03M5.85M5.48M0.01M108.006.07M0.17M18.44M0.21M0.00M
Net Shares Issued and RepurchasedNet Shares Issued
-0.03M5.85M5.48M0.01M108.006.07M0.17M18.44M0.21M0.00M
Net Equity Issued and RepurchasedNet Equity Issued
-0.03M5.85M5.48M0.01M108.006.07M0.17M18.44M0.21M0.00M
Other financing activitiesOther financing
-0.11M
Cash from Financing ActivitiesCash from Financing
-0.05M10.26M-0.15M-0.15M14.75M-0.45M5.75M-0.08M-0.28M-0.18M5.33M-0.14M-0.15M5.92M0.02M-0.15M-0.15M18.29M0.06M-0.15M
Additional items
Exchange Rate EffectFX Effect
454.00-423.00
Change in Cash
-1.07M6.83M-2.29M-2.50M2.56M-2.39M0.51M1.39M-1.60M-0.76M-0.57M1.01M0.27M0.51M0.20M-2.15M0.16M1.99M-0.69M0.72M
Ending Cash Balance
0.65M7.48M5.19M2.69M5.25M2.86M3.37M4.76M3.16M2.40M1.83M2.85M3.12M3.62M3.82M1.67M1.83M3.82M3.12M3.85M
Free Cash FlowFCF
-0.91M-3.18M-2.09M-2.15M-2.29M-1.94M-1.75M-1.57M-1.32M-3.22M-1.43M-2.01M-2.18M-2.24M-2.59M-3.69M-2.23M-5.04M-4.87M-3.14M
Net Cash FlowNCF
-1.07M6.83M-2.29M-2.50M2.56M-2.39M0.51M1.39M-1.60M-0.76M-0.57M1.01M0.27M0.51M0.20M-2.15M0.16M1.99M-0.69M0.72M

Quoin Pharmaceuticals Cash Flow Statement API

Pull Quoin Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=QNRX&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY